Actavis promises to invest in OTC business

19 February 2015 - Deborah Wilkes


Actavis said it would continue to invest in its OTC business, as the company announced plans to change its corporate name to Allergan after it completes the US$66 billion acquisition of the Botox maker.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: